After losing a closely fought battle against unbeaten US boxing champion Floyd Mayweather Jr., Manny Pacquiao's camp has attributed the Filipino boxer's defeat to the denial to receive an anti-inflammatory injection for his right shoulder injury before the bout in Las Vegas on Saturday night.
Mayweather extended his unbeaten record to 48-0 with a unanimous-decision victory over Pacquiao in the 'fight of the century' bout at MGM Grand.
Pacquiao's promoter Bob Arum said Nevada Athletic Commission's refusal to allow an anti-inflammatory shot for the boxer before the mega-bout affected the outcome the fight, News.com.au reported.
Meanwhile, Francisco Aguilar, chairman of the NAC, said that the Pacquiao team did not bring to their notice about his injury until Saturday night, and therefore the requests for permission to take the shot had to be ruled out.
Defending his stance, Pacquiao said that it was a part of the game, claiming that he didn't want to make alibis or complain but insisted that it was hard to fight one-handed.
Arum also said that they felt that the work that was done on the shoulder during training would give him the opportunity to use the right hand without the shot, adding that they were disappointed when the injury kicked up again in the third round.
Despite Pacquiao's limitations, Arum insisted that he fought a courageous fight under all the circumstances, adding that he was very proud of what he had accomplished then.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
